AdipoGenix, Inc.
AdipoGenix, Unigen enter agreement to develop plant-based therapeutics targeting fat
Published in Managed Care Business Week, May 2nd, 2006
AdipoGenix is a biopharmaceutical company developing small molecule therapies for obesity, type 2 diabetes and associated morbidities, and Unigen is a leading natural products research and development facility and supplier of proprietary, biologically active plant-derived ingredients to the natural products and pharmaceutical industries.
Under the terms of the agreement, AdipoGenix and Unigen will equally share in the costs and profits for the discovery, development,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
More Articles from Managed Care Business Week
- Chubb Group of Insurance Companies
Chubb survey finds private companies at increased risk of a liability lawsuit - Johnson & Johnson
Researchers' work from France, the United States and Chile adds to obesity body of knowledge - Professional Education
CMS ensures payment for training medical residents in programs affected by natural disasters - ARC Consulting
Bayer DCA 2000 can be recommended for glycated hemoglobin measurement outside laboratory - Aksys, Ltd.
Aksys closes $5M investment by Durus - American University of Beirut
Prednisolone dose does not seem to affect hepatic glycogen synthesis - More from this issue of Managed Care Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
